Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health For the full story, visit the source.
Business
After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch
Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health
By Avinash Nair· BusinessLine· 5 days ago· 2 min read
This summary is sourced from BusinessLine. Read the full article at:BusinessLine